NDC 31722-851 – Buprenorphine and Naloxone

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC31722-851

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA219727
Marketed since
January 5, 2026
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (1)

Package NDCDescriptionSince
31722-851-3030 TABLET in 1 BOTTLE (31722-851-30)Jan 5, 2026

Other Buprenorphine and Naloxone products